Clinical trial

Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant

NCT00228176

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2005-08-01

PhasePHASE3

Study timeline

Study start (unknown)2005-08-01Date precision: month

Registry last updated2016-05-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Carotid Artery Plaqueunresolved

Arteriosclerosisunresolved

Obesityunresolved

Metabolic Syndrome Xunresolved

Interventions

RimonabantDRUG

Placebo (for Rimonabant)DRUG

Sponsors & collaborators

Sanofilead sponsor

Mapped research locations

BarcelonaSpain1 ParisFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00228176 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.